<?xml version="1.0" encoding="UTF-8"?>
<ref id="B170-molecules-25-05243">
 <label>170.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>C치sedas</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Les</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Gonz치lez-Burgos</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>G칩mez-Serranillos</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>L칩pez</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>Cyanidin-3-
   <italic>O</italic>-glucoside inhibits different enzymes involved in central nervous system pathologies and type-2 diabetes
  </article-title>
  <source>South Afr. J. Bot.</source>
  <year>2019</year>
  <volume>120</volume>
  <fpage>241</fpage>
  <lpage>246</lpage>
  <pub-id pub-id-type="doi">10.1016/j.sajb.2018.07.001</pub-id>
 </element-citation>
</ref>
